Funding for this research was provided by:
chaire INSERM-Ecole Centrale de Nantes
I-SITE NexT (ANR-16-IDEX-0007)
SIRIC ILIAD (INCa-DGOS- Inserm-12558)
Ligue Contre le Cancer
PhD Fellowship INSERM-Région Pays de Loire
Intergroupe Francophone du Myélome
ERC Advanced Grants (EpiR: 741912)
Received: 23 June 2020
Accepted: 19 October 2020
First Online: 2 November 2020
Ethics approval and consent to participate Consent for publication
: Multiple myeloma patients were included in the IFM/DFCI cohort (NCT03679351). All patients signed an informed consent form approved by the Toulouse Ethics Committee.
: The authors declare that they have no competing interests.